HomeCONGRESS

CONGRESS

View Category
Day 2

OPINION: optical frequency domain versus IVUS to guide angioplasty

This multicenter, prospective, randomized controlled study was designed to evaluate the noninferiority of guided angioplasty by optical...
solaci -
Learn More
Day 2

CoreValve Evolut R CE: Good results at 6 months of the new CoreValve repositionable

This study evaluated the safety and efficacy of the new repositionable self-expanding valve. The primary end point...
solaci -
Learn More
Day 2

BVS-STEMI-FIRST OCT study: Bioabsorbable platform in acute myocardial infarction

A bioabsorbable platform implant in the context of ST segment elevation acute myocardial infarction is feasible although...
solaci -
Learn More
Day 2

ADVANCE II CoreValve Trial: Results at six months of self-expanding aortic valve

The CoreValve ADVANCE II Trial is a research study of the best practices to implement this device....
solaci -
Learn More
Day 2

ILUMIEN II: OCT guided stenting versus IVUS

The main predictor of adverse outcomes (thrombosis and restenosis) after implantation of a stent is the degree...
solaci -
Learn More
Day 2

SAPIENS 3: Favorable outcomes with TAVI in intermediate risk patients

Transcatheter aortic valve replacement is a safe and effective alternative to surgery in patients with severe aortic...
solaci -
Learn More
Day 2

ILUMIEN I: Results of the angioplasty indicated by FFR and controlled by OCT

This is an observational, prospective, multicenter study using optical coherence tomography (OCT) and measurement of fractional flow...
solaci -
Learn More
Day 1

Stent eluidor de sirolimus com polímero absorvível apresenta superioridade em relação a stent eluidor de everolimus com polímero durável

Fundamentos: Ainda há controvérsias em relação à superioridade dos polímeros absorvíveis em relação aos polímeros duráveis, e...
solaci -
Learn More